News
The Josep Carreras Foundation and Sant Joan de Déu Create a Childhood Leukemia Research Program Worth Over 10 Million Euros
The Josep Carreras Foundation (FJC), the Josep Carreras Leukemia Research Institute (IJC), and the Sant Joan de Déu Research Institute (IRSJD) have agreed to develop a joint research program on childhood leukemia valued at over 10 million euros.
A study by Sant Joan de Déu identifies the mechanisms that hinder the effectiveness of treatment for diffuse intrinsic pontine glioma in children
DIPG is an aggressive brain tumor that mainly affects pediatric patients and has a poor prognosis in all cases. The research team has identified two key proteins secreted by the tumor that suppress the immune system and promote the formation of barriers that hinder treatment.
Genetic risk for psychiatric disorders is related to emotional and behavioral problems in undiagnosed children
Genetic susceptibility to developing ADHD shows the strongest association with mental problems during childhood and adolescence compared to genetic risk for other psychiatric conditions.
An aggressive childhood cancer case opens new avenues for advanced cell therapies
A positive response to therapy in a paediatric patient with a renal rhabdoid tumour has enabled researchers to identify immune cells with anti-tumour activity in this rare cancer.
Agenda
Defensa tesi doctoral: Desiré Traver Edo
"Análisis de las necesidades a través de las experiencias de mujeres encarceladas desde una mirada del cuidado de la salud y bienestar mental"
Defensa tesi doctoral: M.Trinidad Peláez Martínez
"Eficàcia del Protocol Unificat per al Tractament Transdiagnòstic dels Trastorns Emocionals comòrbids en persones amb estats mentals d'alt risc per a psicosi"
Interviews
Manel González-Piñero
Headof Innovation at CREB UPC and XarTEC SALUT
"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."
Read more More Interviews
